Abstract:Background Contemporary risk scores for ischemic or bleeding event prediction after drug-eluting stent (DES) implantation are limited to the determination of a single time duration for dual antiplatelet therapy (DAPT) and lack flexibility in providing dynamic risk stratification.Objectives This study sought to develop artificial intelligence (AI) models to dynamically predict the ischemic and bleeding risks at different time intervals for patients with DES implantation for personalized decision support for antiplatelet therapy.Methods We identified 81,594 adult patients who received DES implantation in the United States from the Cerner HealthFacts® dataset. The total prediction window covered 12-30 months after DES implantation. We designed eight prediction scenarios with four prediction intervals (3, 6, 12, and 18 months). Five AI models were developed for the ischemic and bleeding risk stratification. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC).Results Our proposed AI model outperformed the clinical guideline-recommended tool–the DAPT score– for 12m-30m prediction (with AUROC 0.82 vs. 0.79 for ischemia, 0.77 vs 0.72 for bleeding). In the scenarios that are not covered by the DAPT score, our models demonstrated robust performance (AUROC ranges were 0.79–0.80 for ischemia and 0.75–0.76 for bleeding).Conclusions As the first effort dedicated to dynamically forecasting adverse endpoints after DES implantation given DAPT continuation or discontinuation, our AI-empowered approach demonstrates superior capabilities for risk stratification, holding value as a novel clinical tool that can refine the prognostic judgments of clinicians and achieve optimal DAPT management.Condensed abstract We proposed an innovative AI-based dynamic prediction system that forecasts the ischemic and bleeding events after coronary stenting in varying time intervals given DAPT continuation or discontinuation. Our AI model not only demonstrated superiority compared with the clinical guideline-recommended tool–the DAPT score in the 12-30 months prediction, but also achieved robust performance in other scenarios that were not covered by the DAPT score. Our AI-driven approach holds value as a novel clinical tool that can refine the prognostic judgments of clinicians, enable better informed clinical decisions, and facilitate optimal DAPT management in the context of precision cardiovascular medicine.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementThis study was funded by the American Heart Association under Award No. 19GPSGC35180031### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board (IRB) at UTHealth has approved the study protocol.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available for licensing at Cerner Corporation* AI : artificial intelligence CABG : coronary artery bypass graft CKD : chronic kidney disease CRUSADE : can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines DAPT : dual antiplatelet therapy PARIS : patterns of non-adherence to antiplatelet regimen in stented patients PCI : percutaneous coronary intervention PRECISE-DAPT : predicting bleeding complication in patients undergoing stent implantation and subsequent dual antiplatelet therapy

A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial

[Study on the Efficiency of the European System for Cardiac Operative Risk Evaluation (euroscore) in Predicting In-Hospital Mortality of the Patients with Percutaneous Coronary Intervention].

A machine learning-based approach for the prediction of periprocedural myocardial infarction by using routine data

Development and validation of a model integrating clinical and coronary lesion-based functional assessment for long-term risk prediction in PCI patients

Predicting Long-Term Ischemic Events Using Routine Clinical Parameters in Patients with Coronary Artery Disease: the OPT-CAD Risk Score.

A scoring system to predict the occurrence of very late stent thrombosis following percutaneous coronary intervention for acute coronary syndrome

Comparative Analysis of the Effectiveness of Riskometer Scales in Predicting the Risk of in-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction After Percutaneous Coronary Intervention

A Novel ABC Score Predicts Mortality in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Who underwent Percutaneous Coronary Intervention

Machine Learning-Based Prediction of In-Stent Restenosis Risk Using Systemic Inflammation Aggregation Index Following Coronary Stent Placement

Machine Learning to Predict Long-Term Cardiac-Relative Prognosis in Patients With Extra-Cardiac Vascular Disease

Merging machine learning and patient preference: a novel tool for risk prediction of percutaneous coronary interventions

Abstract 16422: Development and Validation of a Stent Thrombosis Risk Score in Patients With Acute Coronary Syndromes

Development and Validation of a Risk Nomogram Model for Predicting Revascularization After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome

AI-aided Dynamic Prediction of Bleeding and Ischemic Risk after Coronary Stenting and Subsequent DAPT

Development and Validation of a Risk Score for Predicting 1-Year Mortality Risk of STEMI Based on a Nationwide Cohort in China

Interim prediction of two-year all-cause mortality in patients with de novo multivessel coronary artery disease undergoing intended multivessel PCI

A novel risk stratification model for STEMI after primary PCI: global longitudinal strain and deep neural network assisted myocardial contrast echocardiography quantitative analysis

Machine-learning based risk prediction of in-hospital outcomes following STEMI: the STEMI-ML score

Reevaluation of cardiac risk scores and multiple biomarkers for the prediction of first major cardiovascular events and death in the drug-eluting stent era

An interpretable machine learning method for risk stratification of patients with acute coronary syndrome

Prognostic value of deep learning based RCA PCAT and plaque volume beyond CT-FFR in patients with stent implantation